GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (FRA:PSH0) » Definitions » Other Operating Expense

Sernova Biotherapeutics (FRA:PSH0) Other Operating Expense : €0.02 Mil (TTM As of Jan. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Sernova Biotherapeutics Other Operating Expense?

Sernova Biotherapeutics's Other Operating Expense for the three months ended in Jan. 2025 was €0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jan. 2025 was €0.02 Mil.

Sernova Biotherapeutics's quarterly Other Operating Expense increased from Jul. 2024 (€0.00 Mil) to Oct. 2024 (€0.01 Mil) but then declined from Oct. 2024 (€0.01 Mil) to Jan. 2025 (€0.00 Mil).

Sernova Biotherapeutics's annual Other Operating Expense declined from Oct. 2022 (€0.02 Mil) to Oct. 2023 (€0.02 Mil) but then increased from Oct. 2023 (€0.02 Mil) to Oct. 2024 (€0.02 Mil).


Sernova Biotherapeutics Other Operating Expense Historical Data

The historical data trend for Sernova Biotherapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Other Operating Expense Chart

Sernova Biotherapeutics Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.02 0.02 0.02

Sernova Biotherapeutics Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 - 0.01 -

Sernova Biotherapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova Biotherapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova Biotherapeutics Business Description

Traded in Other Exchanges
Address
700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Sernova Biotherapeutics Headlines

No Headlines